These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 14642796

  • 1. The cyclo-oxygenase-2 inhibitor, rofecoxib, attenuates mucosal damage due to colitis induced by trinitrobenzene sulphonic acid in rats.
    Martín AR, Villegas I, La Casa C, Alarcón de la Lastra C.
    Eur J Pharmacol; 2003 Nov 28; 481(2-3):281-91. PubMed ID: 14642796
    [Abstract] [Full Text] [Related]

  • 2. Influence of simultaneous inhibition of cyclooxygenase-2 and inducible nitric oxide synthase in experimental colitis in rats.
    Dudhgaonkar SP, Tandan SK, Kumar D, Raviprakash V, Kataria M.
    Inflammopharmacology; 2007 Oct 28; 15(5):188-95. PubMed ID: 17943250
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inhibition of endogenous nitric oxide activity impairs the colonic sparing effect of rofecoxib, the cyclooxygenase-2 inhibitor and resveratrol, the preferential cyclooxygenase-1 inhibitor in the course of experimental colitis. Role of oxidative stress biomarkers and proinflammatory cytokines.
    Kwiecień S, Wojcik-Grzybek D, Sliwowski Z, Targosz A, Chmura A, Magierowska K, Strzalka M, Glowacka U, Ptak-Belowska A, Magierowski M, Brzozowski T.
    J Physiol Pharmacol; 2023 Oct 28; 74(5):. PubMed ID: 38085520
    [Abstract] [Full Text] [Related]

  • 7. PARP inhibition reduces acute colonic inflammation in rats.
    Sánchez-Fidalgo S, Villegas I, Martín A, Sánchez-Hidalgo M, Alarcón de la Lastra C.
    Eur J Pharmacol; 2007 Jun 01; 563(1-3):216-23. PubMed ID: 17374531
    [Abstract] [Full Text] [Related]

  • 8. Healing impairment effect of cyclooxygenase inhibitors on dextran sulfate sodium-induced colitis in rats.
    Tsubouchi R, Hayashi S, Aoi Y, Nishio H, Terashima S, Kato S, Takeuchi K.
    Digestion; 2006 Jun 01; 74(2):91-100. PubMed ID: 17143008
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Up-regulation of cyclooxygenase-2 by inhibition of cyclooxygenase-1: a key to nonsteroidal anti-inflammatory drug-induced intestinal damage.
    Tanaka A, Hase S, Miyazawa T, Takeuchi K.
    J Pharmacol Exp Ther; 2002 Mar 01; 300(3):754-61. PubMed ID: 11861778
    [Abstract] [Full Text] [Related]

  • 11. Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events.
    Tanaka A, Hase S, Miyazawa T, Ohno R, Takeuchi K.
    J Pharmacol Exp Ther; 2002 Dec 01; 303(3):1248-54. PubMed ID: 12438549
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antibiotic treatment with ampicillin accelerates the healing of colonic damage impaired by aspirin and coxib in the experimental colitis. Importance of intestinal bacteria, colonic microcirculation and proinflammatory cytokines.
    Zwolinska-Wcislo M, Krzysiek-Maczka G, Ptak-Belowska A, Karczewska E, Pajdo R, Sliwowski Z, Urbanczyk K, Drozdowicz D, Konturek SJ, Pawlik WW, Brzozowski T.
    J Physiol Pharmacol; 2011 Jun 01; 62(3):357-68. PubMed ID: 21893697
    [Abstract] [Full Text] [Related]

  • 15. Acetic acid-derived prostaglandin-dependent colonic adaptive cytoprotection is preserved in chronic colitis: role of cyclo-oxygenase.
    Ohara K, Kono T, Chisato N, Asama T, Yoneda M, Kasai S.
    Int J Colorectal Dis; 2003 May 01; 18(3):260-6. PubMed ID: 12673493
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. An oral drug delivery system targeting immune-regulating cells ameliorates mucosal injury in trinitrobenzene sulfonic acid-induced colitis.
    Nakase H, Okazaki K, Tabata Y, Uose S, Ohana M, Uchida K, Nishi T, Debreceni A, Itoh T, Kawanami C, Iwano M, Ikada Y, Chiba T.
    J Pharmacol Exp Ther; 2001 Jun 01; 297(3):1122-8. PubMed ID: 11356937
    [Abstract] [Full Text] [Related]

  • 18. In vitro study of tocolytic effect of rofecoxib, a specific cyclo-oxygenase 2 inhibitor. Comparison and combination with other tocolytic agents.
    Doret M, Mellier G, Benchaib M, Piacenza JM, Gharib C, Pasquier JC.
    BJOG; 2002 Sep 01; 109(9):983-8. PubMed ID: 12269693
    [Abstract] [Full Text] [Related]

  • 19. Rofecoxib produces intestinal but not gastric damage in the presence of a low dose of indomethacin in rats.
    Yokota A, Taniguchi M, Takahira Y, Tanaka A, Takeuchi K.
    J Pharmacol Exp Ther; 2005 Jul 01; 314(1):302-9. PubMed ID: 15831440
    [Abstract] [Full Text] [Related]

  • 20. Concurrent infection with Schistosoma mansoni attenuates inflammation induced changes in colonic morphology, cytokine levels, and smooth muscle contractility of trinitrobenzene sulphonic acid induced colitis in rats.
    Moreels TG, Nieuwendijk RJ, De Man JG, De Winter BY, Herman AG, Van Marck EA, Pelckmans PA.
    Gut; 2004 Jan 01; 53(1):99-107. PubMed ID: 14684583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.